ID   S22A7_RAT               Reviewed;         535 AA.
AC   Q5RLM2; Q63314;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   21-DEC-2004, sequence version 1.
DT   02-OCT-2024, entry version 124.
DE   RecName: Full=Solute carrier family 22 member 7 {ECO:0000303|PubMed:11504818};
DE   AltName: Full=Novel liver transporter {ECO:0000303|PubMed:8056831};
DE   AltName: Full=Organic anion transporter 2 {ECO:0000303|PubMed:9650585};
DE            Short=rOAT2 {ECO:0000303|PubMed:11504818};
GN   Name=Slc22a7 {ECO:0000312|RGD:621699}; Synonyms=Nlt, Oat2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=8056831; DOI=10.1242/jcs.107.4.1065;
RA   Simonson G.D., Vincent A.C., Roberg K.J., Huang Y., Iwanij V.;
RT   "Molecular cloning and characterization of a novel liver-specific transport
RT   protein.";
RL   J. Cell Sci. 107:1065-1072(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley;
RA   Bourgea J., White E.P., Patten C.J., Crespi C.L., Xiao G.;
RT   "A novel rat organic anion transporter 2.";
RL   Submitted (NOV-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   FUNCTION, TRANSPORTER ACTIVITY, TISSUE SPECIFICITY, AND MISCELLANEOUS.
RX   PubMed=9650585; DOI=10.1016/s0014-5793(98)00585-7;
RA   Sekine T., Cha S.H., Tsuda M., Apiwattanakul N., Nakajima N., Kanai Y.,
RA   Endou H.;
RT   "Identification of multispecific organic anion transporter 2 expressed
RT   predominantly in the liver.";
RL   FEBS Lett. 429:179-182(1998).
RN   [4]
RP   FUNCTION, TRANSPORTER ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, TISSUE
RP   SPECIFICITY, AND MISCELLANEOUS.
RX   PubMed=11504818;
RA   Morita N., Kusuhara H., Sekine T., Endou H., Sugiyama Y.;
RT   "Functional characterization of rat organic anion transporter 2 in LLC-PK1
RT   cells.";
RL   J. Pharmacol. Exp. Ther. 298:1179-1184(2001).
RN   [5]
RP   FUNCTION, AND MISCELLANEOUS.
RX   PubMed=15900017; DOI=10.1124/dmd.104.001552;
RA   Morita N., Kusuhara H., Nozaki Y., Endou H., Sugiyama Y.;
RT   "Functional involvement of rat organic anion transporter 2 (Slc22a7) in the
RT   hepatic uptake of the nonsteroidal anti-inflammatory drug ketoprofen.";
RL   Drug Metab. Dispos. 33:1151-1157(2005).
RN   [6]
RP   INDUCTION, AND TISSUE SPECIFICITY.
RX   PubMed=16885152; DOI=10.1152/ajprenal.00207.2006;
RA   Ljubojevic M., Balen D., Breljak D., Kusan M., Anzai N., Bahn A.,
RA   Burckhardt G., Sabolic I.;
RT   "Renal expression of organic anion transporter OAT2 in rats and mice is
RT   regulated by sex hormones.";
RL   Am. J. Physiol. 292:F361-F372(2007).
RN   [7]
RP   FUNCTION, TRANSPORTER ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=21446918; DOI=10.1042/bj20101904;
RA   Fork C., Bauer T., Golz S., Geerts A., Weiland J., Del Turco D.,
RA   Schoemig E., Gruendemann D.;
RT   "OAT2 catalyses efflux of glutamate and uptake of orotic acid.";
RL   Biochem. J. 436:305-312(2011).
RN   [8]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=25904762; DOI=10.1124/dmd.114.062364;
RA   Shen H., Liu T., Morse B.L., Zhao Y., Zhang Y., Qiu X., Chen C.,
RA   Lewin A.C., Wang X.T., Liu G., Christopher L.J., Marathe P., Lai Y.;
RT   "Characterization of Organic Anion Transporter 2 (SLC22A7): A Highly
RT   Efficient Transporter for Creatinine and Species-Dependent Renal Tubular
RT   Expression.";
RL   Drug Metab. Dispos. 43:984-993(2015).
CC   -!- FUNCTION: Functions as a Na(+)-independent bidirectional multispecific
CC       transporter (PubMed:11504818, PubMed:15900017, PubMed:21446918,
CC       PubMed:9650585). Contributes to the renal and hepatic elimination of
CC       endogenous organic compounds from the systemic circulation into the
CC       urine and bile, respectively (PubMed:25904762). Capable of transporting
CC       a wide range of purine and pyrimidine nucleobases, nucleosides, and
CC       nucleotides with cGMP, 2'deoxyguanosine and GMP being the preferred
CC       substrates (By similarity). Functions as a pH- and chloride-independent
CC       cGMP bidirectional facilitative transporter that can regulate both
CC       intracellular and extracellular levels of cGMP and may be involved in
CC       cGMP signaling pathways (By similarity). Mediates orotate/glutamate
CC       bidirectional exchange and most likely display a physiological role in
CC       hepatic release of glutamate into the blood (PubMed:21446918). Involved
CC       in renal secretion and possible reabsorption of creatinine (By
CC       similarity). Able to uptake prostaglandin E2 (PGE2) and may contribute
CC       to PGE2 renal excretion (PubMed:11504818, PubMed:9650585). Also
CC       transports alpha-ketoglutarate and urate (PubMed:9650585). Apart from
CC       the orotate/glutamate exchange, the counterions for the uptake of other
CC       SLC22A7/OAT2 substrates remain to be identified (By similarity).
CC       {ECO:0000250|UniProtKB:Q9Y694, ECO:0000269|PubMed:11504818,
CC       ECO:0000269|PubMed:15900017, ECO:0000269|PubMed:21446918,
CC       ECO:0000269|PubMed:25904762, ECO:0000269|PubMed:9650585}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-glutamate(in) + orotate(out) = L-glutamate(out) +
CC         orotate(in); Xref=Rhea:RHEA:72043, ChEBI:CHEBI:29985,
CC         ChEBI:CHEBI:30839; Evidence={ECO:0000269|PubMed:21446918};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3',5'-cyclic GMP(in) = 3',5'-cyclic GMP(out);
CC         Xref=Rhea:RHEA:76207, ChEBI:CHEBI:57746;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y694};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=GMP(in) = GMP(out); Xref=Rhea:RHEA:76211, ChEBI:CHEBI:58115;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y694};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2'-deoxyguanosine(in) = 2'-deoxyguanosine(out);
CC         Xref=Rhea:RHEA:76215, ChEBI:CHEBI:17172;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y694};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=GDP(in) = GDP(out); Xref=Rhea:RHEA:76219, ChEBI:CHEBI:58189;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y694};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=guanosine(in) = guanosine(out); Xref=Rhea:RHEA:75371,
CC         ChEBI:CHEBI:16750; Evidence={ECO:0000250|UniProtKB:Q9Y694};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=GTP(in) = GTP(out); Xref=Rhea:RHEA:75787, ChEBI:CHEBI:37565;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y694};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3',5'-cyclic AMP(in) = 3',5'-cyclic AMP(out);
CC         Xref=Rhea:RHEA:76223, ChEBI:CHEBI:58165;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y694};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=creatinine(in) = creatinine(out); Xref=Rhea:RHEA:74539,
CC         ChEBI:CHEBI:16737; Evidence={ECO:0000250|UniProtKB:Q9Y694};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=prostaglandin E2(out) = prostaglandin E2(in);
CC         Xref=Rhea:RHEA:50984, ChEBI:CHEBI:606564;
CC         Evidence={ECO:0000269|PubMed:11504818, ECO:0000269|PubMed:9650585};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-oxoglutarate(in) = 2-oxoglutarate(out);
CC         Xref=Rhea:RHEA:76231, ChEBI:CHEBI:16810;
CC         Evidence={ECO:0000269|PubMed:9650585};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glutarate(in) = glutarate(out); Xref=Rhea:RHEA:76251,
CC         ChEBI:CHEBI:30921; Evidence={ECO:0000250|UniProtKB:Q91WU2};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=urate(out) = urate(in); Xref=Rhea:RHEA:60368,
CC         ChEBI:CHEBI:17775; Evidence={ECO:0000250|UniProtKB:Q9Y694};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=estrone 3-sulfate(out) = estrone 3-sulfate(in);
CC         Xref=Rhea:RHEA:71835, ChEBI:CHEBI:60050;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y694};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=38.5 uM for prostaglandin E2 {ECO:0000269|PubMed:11504818};
CC         KM=200 uM for orotate {ECO:0000269|PubMed:21446918};
CC         KM=1200 uM for glutamate {ECO:0000269|PubMed:21446918};
CC         Vmax=520 nmol/min/mg protein for prostaglandin E2 uptake
CC         {ECO:0000269|PubMed:11504818};
CC         Vmax=13.2 nmol/min/mg protein for orotate uptake
CC         {ECO:0000269|PubMed:21446918};
CC         Vmax=39 nmol/min/mg protein for glutamate uptake
CC         {ECO:0000269|PubMed:21446918};
CC   -!- SUBCELLULAR LOCATION: Basolateral cell membrane
CC       {ECO:0000269|PubMed:8056831}; Multi-pass membrane protein
CC       {ECO:0000305}. Apical cell membrane {ECO:0000269|PubMed:25904762};
CC       Multi-pass membrane protein {ECO:0000305}. Cell membrane
CC       {ECO:0000250|UniProtKB:Q9Y694}; Multi-pass membrane protein
CC       {ECO:0000305}. Note=Located to the sinusoidal/basolateral membrane of
CC       hepatocytes (PubMed:8056831). Apical side of the renal tubule
CC       (PubMed:25904762). {ECO:0000269|PubMed:25904762,
CC       ECO:0000269|PubMed:8056831}.
CC   -!- TISSUE SPECIFICITY: Expressed in liver and kidney (PubMed:11504818,
CC       PubMed:16885152, PubMed:21446918, PubMed:25904762, PubMed:8056831,
CC       PubMed:9650585). Expressed at low levels in adipose tissue
CC       (PubMed:8056831). Expressed in fetal liver (PubMed:8056831). In kidney,
CC       expressed at the brush border of the proximal tubule S3 segment (S3) in
CC       the outer stripe and medullary rays (PubMed:16885152, PubMed:25904762).
CC       In kidney, expression is higher in female than male (PubMed:16885152).
CC       {ECO:0000269|PubMed:11504818, ECO:0000269|PubMed:16885152,
CC       ECO:0000269|PubMed:21446918, ECO:0000269|PubMed:25904762,
CC       ECO:0000269|PubMed:8056831, ECO:0000269|PubMed:9650585}.
CC   -!- INDUCTION: Strongly inhibited by androgen, and weakly stimulated by
CC       estrogen and progesterone, which results in gender differences (female
CC       > male) that appears in puberty, for expression in kidney.
CC       {ECO:0000269|PubMed:16885152}.
CC   -!- MISCELLANEOUS: Involved in the uptake of clinically used drugs such as
CC       ketoprofen, indomethacin and methotrexate, and contributes to renal and
CC       hepatic drug elimination. {ECO:0000269|PubMed:11504818,
CC       ECO:0000269|PubMed:15900017, ECO:0000269|PubMed:9650585}.
CC   -!- SIMILARITY: Belongs to the major facilitator (TC 2.A.1) superfamily.
CC       Organic cation transporter (TC 2.A.1.19) family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L27651; AAA57157.1; -; mRNA.
DR   EMBL; AY816233; AAV66454.1; -; mRNA.
DR   RefSeq; NP_445989.2; NM_053537.2.
DR   AlphaFoldDB; Q5RLM2; -.
DR   SMR; Q5RLM2; -.
DR   STRING; 10116.ENSRNOP00000025094; -.
DR   BindingDB; Q5RLM2; -.
DR   ChEMBL; CHEMBL2073671; -.
DR   TCDB; 2.A.1.19.15; the major facilitator superfamily (mfs).
DR   PhosphoSitePlus; Q5RLM2; -.
DR   PaxDb; 10116-ENSRNOP00000025094; -.
DR   Ensembl; ENSRNOT00000025094.6; ENSRNOP00000025094.3; ENSRNOG00000018420.8.
DR   Ensembl; ENSRNOT00055012269; ENSRNOP00055009722; ENSRNOG00055007370.
DR   Ensembl; ENSRNOT00060040836; ENSRNOP00060033773; ENSRNOG00060023561.
DR   Ensembl; ENSRNOT00065046445; ENSRNOP00065038077; ENSRNOG00065026912.
DR   GeneID; 89776; -.
DR   KEGG; rno:89776; -.
DR   UCSC; RGD:621699; rat.
DR   AGR; RGD:621699; -.
DR   CTD; 10864; -.
DR   RGD; 621699; Slc22a7.
DR   eggNOG; KOG0255; Eukaryota.
DR   GeneTree; ENSGT00940000154922; -.
DR   HOGENOM; CLU_001265_33_3_1; -.
DR   InParanoid; Q5RLM2; -.
DR   OMA; QAFFYNA; -.
DR   OrthoDB; 2088942at2759; -.
DR   PhylomeDB; Q5RLM2; -.
DR   TreeFam; TF315847; -.
DR   Reactome; R-RNO-561048; Organic anion transport.
DR   Reactome; R-RNO-9749641; Aspirin ADME.
DR   SABIO-RK; Q5RLM2; -.
DR   PRO; PR:Q5RLM2; -.
DR   Proteomes; UP000002494; Chromosome 9.
DR   Bgee; ENSRNOG00000018420; Expressed in liver and 6 other cell types or tissues.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0009925; C:basal plasma membrane; ISS:UniProtKB.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0015139; F:alpha-ketoglutarate transmembrane transporter activity; ISS:UniProtKB.
DR   GO; GO:0008514; F:organic anion transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0015132; F:prostaglandin transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0015347; F:sodium-independent organic anion transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0022857; F:transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0015742; P:alpha-ketoglutarate transport; ISS:UniProtKB.
DR   GO; GO:0006811; P:monoatomic ion transport; IEA:UniProtKB-KW.
DR   GO; GO:0015711; P:organic anion transport; IDA:RGD.
DR   GO; GO:0015732; P:prostaglandin transport; IDA:UniProtKB.
DR   GO; GO:0035634; P:response to stilbenoid; ISO:RGD.
DR   Gene3D; 1.20.1250.20; MFS general substrate transporter like domains; 1.
DR   InterPro; IPR020846; MFS_dom.
DR   InterPro; IPR005828; MFS_sugar_transport-like.
DR   InterPro; IPR036259; MFS_trans_sf.
DR   InterPro; IPR004749; Orgcat_transp/SVOP.
DR   NCBIfam; TIGR00898; 2A0119; 1.
DR   PANTHER; PTHR24064; SOLUTE CARRIER FAMILY 22 MEMBER; 1.
DR   PANTHER; PTHR24064:SF33; SOLUTE CARRIER FAMILY 22 MEMBER 7; 1.
DR   Pfam; PF00083; Sugar_tr; 1.
DR   SUPFAM; SSF103473; MFS general substrate transporter; 1.
DR   PROSITE; PS50850; MFS; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Ion transport; Membrane; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN           1..535
FT                   /note="Solute carrier family 22 member 7"
FT                   /id="PRO_0000317486"
FT   TRANSMEM        21..41
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        144..164
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        178..198
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        202..222
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        232..252
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        257..277
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        344..364
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        375..395
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        402..422
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        429..449
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        464..484
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        489..509
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   CONFLICT        479
FT                   /note="P -> R (in Ref. 1; AAA57157)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   535 AA;  58654 MW;  E7C38969DCAE2B73 CRC64;
     MGFEDLLDKV GGFGPFQLRN LVLMALPRML LPMHFLLPVF MAAVPAHHCA LPGAPANLSH
     QDLWLEAHLP RETDGSFSSC LRFAYPQTVP NVTLGTEVSN SGEPEGEPLT VPCSQGWEYD
     RSEFSSTIAT EWDLVCQQRG LNKITSTCFF IGVLVGAVVY GYLSDRFGRR RLLLVAYVSS
     LVLGLMSAAS INYIMFVVTR TLTGSALAGF TIIVLPLELE WLDVEHRTVA GVISTVFWSG
     GVLLLALVGY LIRSWRWLLL AATLPCVPGI ISIWWVPESA RWLLTQGRVE EAKKYLLSCA
     KLNGRPVGEG SLSQEALNNV VTMERALQRP SYLDLFRTSQ LRHISLCCMM VWFGVNFSYY
     GLTLDVSGLG LNVYQTQLLF GAVELPSKIM VYFLVRRLGR RLTEAGMLLG AALTFGTSLL
     VSLETKSWIT ALVVVGKAFS EAAFTTAYLF TSELYPTVLR QTGLGLTALM GRLGASLAPL
     AALLDGVWLL LPKVAYGGIA LVAACTALLL PETKKAQLPE TIQDVERKST QEEDV
//
